# A Trial of SHR-1703 in Asthma

> **NCT05042401** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 23 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SHR-1703
- **DRUG:** placebo
- **DRUG:** SHR-1703
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05042401
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-12
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-06-15
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05042401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05042401, "A Trial of SHR-1703 in Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05042401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*